Выпуск
The Predicament of Patients in Prison: A Hematology Perspective
HemeTalks: Conversations in Hematology Education · 19 ноября 2026 г. · 30 мин
Dr. Michael DeBaun, Professor of Pediatrics and Medicine at Vanderbilt University Medical Center, joins HemeTalks hosts Drs. Ronak Mistry and Vivek Patel to discuss a population often left out of conversations about equitable hematologic care: patients who are incarcerated or moving through the criminal legal system. Nearly 80 million Americans carry a criminal record, and incarceration is associated with higher rates of chronic disease, morbidity, and mortality. The conversation examines what quality hematologic care looks like inside correctional facilities, what happens at the moment of release, and how barriers to housing, employment, and insurance compound medical risk after reentry. It also explores what hematologists can do to close these gaps and ensure continuity of care. Clinical Pearls A hematologic diagnosis doesn't pause at the prison gate. Patients carry their disease into jail or prison and back out again, and incarceration itself is associated with higher chronic disease burden, morbidity, and mortality. Hematologists should treat correctional facilities as a legitimate care setting that deserves the same standard of care as any other. Dr. DeBaun also calls on our hematology community to ensure that our treatment guidelines consider patients in correctional facilities. Release is a high-risk transition that needs a plan before the patient leaves. Because the same health issues are waiting on the outside, continuity of care can't be left to chance. Coordinating medications, records, and follow-up with the patient's release should be part of the plan for anyone with a hematologic condition. Housing, employment, and insurance barriers are clinical variables. A criminal record can block the very resources that make treatment adherence and follow-up possible. When a patient misses visits or therapy after reentry, look for these structural barriers before assuming nonadherence. References: 1. DeBaun MR, Staples-Horne M, Sadacharan R, Braverman P, Shah N, Strouse J, et al. Implementing ASH’s guidelines for acute medical care for incarcerated children and adults with sickle cell disease. Blood Adv. 2025;9(11):2744-50. 2. Dickens C, Ramesh A, Adanlawo T, DeBaun MR. Time-sensitive healthcare guidelines for youth with chronic diseases in custody: gaps in care. Pediatr Res. 2024;95(6):1418-21. 3. National Cancer Institute. CAR T cells: engineering immune cells to treat cancer [Internet]. Bethesda (MD): National Cancer Institute; 2025 Feb 26 [cited 2026 Sep 22]. 4. National Cancer Institute. Tecvayli produces promising results in multiple myeloma [Internet]. Bethesda (MD): National Cancer Institute; 2022 Sep 29 [cited 2026 Sep 22]. 5. Centers for Medicare & Medicaid Services. Reentry services for incarcerated individuals [Internet]. Baltimore (MD): Centers for Medicare & Medicaid Services; [cited 2026 Sep 22].